A meta-analysis of the association between angiotensin-converting enzyme insertion/ deletion gene polymorphism and the risk of overweight/obesity

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 16, Issue 3, 2015, Pages 687-694

  Mao, Song ^a   Huang, Songming ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme; gene polymorphism; meta analysis; overweight obesity

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ACE PROTEIN, HUMAN;

AFRICAN; ANGIOTENSIN CONVERTING ENZYME GENE; ARTICLE; ASIAN; CAUCASIAN; DNA POLYMORPHISM; ETHNIC DIFFERENCE; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INDEL MUTATION; OBESITY; POPULATION RESEARCH; RISK ASSESSMENT; SYSTEMATIC REVIEW; BLACK PERSON; CONFIDENCE INTERVAL; ENZYMOLOGY; GENETIC ASSOCIATION STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; ODDS RATIO; PUBLISHING; RISK FACTOR;

AFRICAN CONTINENTAL ANCESTRY GROUP; CONFIDENCE INTERVALS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDEL MUTATION; OBESITY; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RISK FACTORS;

EID: 84950313277     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320313501218     Document Type: Article

References (36)

1. Shigeta H, Shigeta M, Atsuko N, et al. Lifestyle, obesity, and insulin resistance. Am Diabetes Assoc 2001; 24: 608-611.
2. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113: 898-918.
3. Bray GA,. Obesity. Lippincott Company: Philadelphia, 1992.
4. Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: A 26 years follow up participants in Framingham Heart Study. Circulation 1983; 67: 968-977.
5. Yang SJ, Kim S, Park H, et al. Sex-dependent association between angiotensin-converting enzyme insertion/deletion polymorphism and obesity in relation to sodium intake in children. Nutrition 2013; 29: 525-530.
6. Bell CG, Walley AJ, Froguel P,. The genetics of human obesity. Nat Rev Genet 2005; 6: 221-234.
7. Jones BH, Standridgr MK, Moustaid N,. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 1997; 138: 1512-1519.
8. Settin AA, Algasham A, Dowaidar M, et al. Methylene tetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms related to overweight/obesity among Saudi subjects from Qassim Region. Dis Markers 2009; 27: 97-102.
9. Xi B, Ruiter R, Chen J, et al. The ACE insertion/deletion polymorphism and its association with metabolic syndrome. Metabolism 2012; 61: 891-897.
10. Mehri S, Mahjoub S, Hammami S, et al. Renin-angiotensin system polymorphisms in relation to hypertension status and obesity in a Tunisian population. Mol Biol Rep 2012; 39: 4059-4065.
11. Bell CG, Meyre D, Petretto E, et al. No contribution of angiotensin-converting enzyme (ACE) gene variants to severe obesity: A model for comprehensive case/control and quantitative cladistic analysis of ACE in human diseases. Eur J Hum Genet 2007; 15: 320-327.
12. Akin F, Turgut S, Bastemir M, et al. Angiotensin-converting enzyme gene polymorphism in overweight and obese Turkish patients with insulin resistance. DNA Cell Biol 2010; 29: 207-212.
13. Fiatal S, Szigethy E, Széles G, et al. Insertion/deletion polymorphism of angiotensin-1 converting enzyme is associated with metabolic syndrome in Hungarian adults. J Renin Angiotensin Aldosterone Syst 2011; 12: 531-538.
14. Kim K,. Association of angiotensin-converting enzyme insertion/deletion polymorphism with obesity, cardiovascular risk factors and exercise-mediated changes in Korean women. Eur J Appl Physiol 2009; 105: 879-887.
15. Sinorita H, Madiyan M, Pramono RB, et al. ACE gene insertion/deletion polymorphism among patients with type 2 diabetes, and its relationship with metabolic syndrome at Sardjito Hospital Yogyakarta, Indonesia. Acta Med Indones 2010; 42: 12-16.
16. Strazzullo P, Iacone R, Iacoviello L, et al. Genetic variation in the renin-angiotensin system and abdominal adiposity in men: The Olivetti Prospective Heart Study. Ann Intern Med 2003; 138: 17-24.
17. Bitigen A, Cevik C, Demir D, et al. The frequency of angiotensin-converting enzyme genotype and left ventricular functions in the obese population. Congest Heart Fail 2007; 13: 323-327.
18. Cooper R, McFarlane-Anderson N, Bennett FI, et al. ACE, angiotensinogen and obesity: A potential pathway leading to hypertension. J Hum Hypertens 1997; 11: 107-111.
19. El-Hazmi MA, Warsy AS,. Increased frequency of angiotensin-converting enzyme DD genotype in Saudi overweight and obese patients. Ann Saudi Med 2003; 23: 24-27.
20. Wacker MJ, Godard MP, McCabe EH, et al. Sex difference in the association of the angiotensin converting enzyme I/D polymorphism and body mass index. Med Sci Monit 2008; 14: 353-357.
21. Toniutto P, Fabris C, Minisini R, et al. Weight gain after liver transplantation and the insertion / deletion polymorphism of the angiotensin-converting enzyme gene. Transplantation 2005; 79: 1338-1343.
22. Zhou JB, Liu C, Niu WY, et al. Contributions of renin-angiotensin system-related gene interactions to obesity in a Chinese population. PloS One 2012; 7: 1-6.
23. Boustany CM, Bharadwaj K, Daugherty A, et al. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 2004; 287: 943-949.
24. Sharma AM, Janke J, Gorzelniak K, et al. Angiotensinogen blockade prevents type 2 diabetes by formation of fat cells. Hypertension 2002; 40: 609-611.
25. Clasen R, Schupp M, Foryst-Ludwig A, et al. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin. Hypertension 2005; 46: 137-143.
26. Cox R, Bouzekri N, Martin S, et al. Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. Hum Mol Genet 2002; 11: 2969-2977.
27. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin -converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
28. Niu T, Chen X, Xu X,. Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: Therapeutic implications. Drugs 2002; 62: 977-993.
29. Li Y,. Angiotensin-converting enzyme gene insertion/deletion polymorphism and essential hypertension in the Chinese population: A meta-analysis including 21,058 participants. Intern Med J 2012; 42: 439-444.
30. Niu W, Qi Y, Gao P, et al. Angiotensin converting enzyme D allele is associated with an increased risk of type 2 diabetes: Evidence from a meta-analysis. Endocr J 2010; 57: 431-438.
31. Celik O, Yesilada E, Hascalik S, et al. Angiotensin-converting enzyme gene polymorphism and risk of insulin resistance in PCOS. Reprod Biomed Online 2010; 20: 492-498.
32. You CH, Hong YS, Kwak JY, et al. The relationship between ACE I/D polymorphism and HDL cholesterol. J Prev Med Public Health 2006; 39: 505-510.
33. Passaro A, Dalla NE, Marcello C, et al. PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome. Cardiovascular Diabetol 2011; 10: 1-8.
34. Min J, Kim YJ, Lee H, et al. Is the association between ACE genes and blood pressure mediated by postnatal growth during the first 3 years? Early Hum Dev 2012; 88: 425-429.
35. Kotaska K, Kolarova J, Kotrcova K, et al. Correlation between common genetic variants and risk factors associated with prediction of cardiovascular diseases in dyslipidemic patients. Genet Test Mol Biomarkers 2012; 16: 210-214.
36. Borzyszkowska J, Stanislawska-Sachadyn A, Wirtwein M, et al. Angiotensin converting enzyme gene polymorphism is associated with severity of coronary artery disease in men with high total cholesterol levels. J Appl Genet 2012; 53: 175-182.